Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.
Also called NCT03418233
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 115 participants
- Registry
-
NCT03418233
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Poland
- Registry status
- Completed
Technical summary
Registry record NCT03418233. Randomized; quadruple masking; primary purpose treatment. Start 2018-04-19 (actual); primary completion 2021-01-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Clinical Trial to Evaluate the Regenerative Capacity of CardioCell in Patients With Chronic Ischaemic Heart Failure (CIHF)
- Condition
- Heart Failure
- Intervention (Drug)
- CardioCell
- Intervention (Drug)
- Placebos
- Lead sponsor
- John Paul II Hospital, Krakow
- Collaborator
- KCRI
- Collaborator
- National Center for Research and Development, Poland
Record details
- Record id
cardio:ct-nct03418233- Content hash
4bbd02f38e6dd0dcad4c04f9db6022521995803f549a6d0c483844824d33a253